Company profile
Attovia Therapeutics, Inc.
NASDAQ:ATTOBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06787586 | phase1 | active_not_recruiting | 2025-01-14 | 2026-05-01 | Attovia Therapeutics Inc | Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus |
| NCT07205081 | phase1 | active_not_recruiting | 2025-10-22 | 2026-10-01 | Attovia Therapeutics Inc | Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis |
FDA applications (0)
No records yet.